Read + Share
Amedeo Smart
Independent Medical Education
Ito K, Kita Y, Kobayashi T. Real-world outcomes of pembrolizumab for platinum-refractory advanced urothelial carcinoma: Efficacy, safety, and evidence for trial-unfit patients. Int J Urol 2023;30:696-703.PMID: 36482843
Email
LinkedIn
Facebook
Twitter
Privacy Policy